|
|
The parmacokinetics and biological effects of an recombinant methionyl growth hormone(LBD-003) produced by the expression of genomic hGH in a yeast cell line, were studied in growth hormone deficient children.
Twelve patients were randomly assigned to two age-matched subcutaneous and intramuscular groups. Each group consists of 6 patients.
Each subject received an dosage of 0.1 U hGH(LBD-003)/kg, BW, Blood was drawn before... |
